Progress on novel compounds for the treatment of bone metabolism-related disorders: focus on osteoporosis and beyond
{{output}}
Bone metabolism-related disorders represent a significant global health burden, due to their high prevalence and substantial socioeconomic costs, particularly osteoporosis. Conventional antiresorptive and anabolic agents have well-established clinical utility,... ...
